Virus World
378.2K views | +0 today
Follow
Virus World
Virus World provides a daily blog of the latest news in the Virology field and the COVID-19 pandemic. News on new antiviral drugs, vaccines, diagnostic tests, viral outbreaks, novel viruses and milestone discoveries are curated by expert virologists. Highlighted news include trending and most cited scientific articles in these fields with links to the original publications. Stay up-to-date with the most exciting discoveries in the virus world and the last therapies for COVID-19 without spending hours browsing news and scientific publications. Additional comments by experts on the topics are available in Linkedin (https://www.linkedin.com/in/juanlama/detail/recent-activity/)
Curated by Juan Lama
Your new post is loading...
Scooped by Juan Lama
Scoop.it!

H5N1 Avian Influenza Detected In New York City’s Wild Birds 

H5N1 Avian Influenza Detected In New York City’s Wild Birds  | Virus World | Scoop.it

Scientists have found several strains of highly pathogenic avian influenza in a small number of NYC’s wild birds. A recent study has found a very small number of wild urban birds that either live in or migrate through New York City are carrying an unexpected hitchhiker: the highly pathogenic avian influenza virus H5N1 (ref). This worrying discovery demonstrates that potentially serious human health risks are not limited to rural environments or to commercial factory farms as most people believe, but can also be found lurking in large cities. Thus, this study — the first of its kind — highlights the dangers of close contact between animals and humans because they may end up sharing infections — or even pandemics. “To my knowledge, this is the first large-scale U.S. study of avian influenza in an urban area, and the first with active community involvement,” the study’s senior author, microbiologist and geneticist Christine Marizzi, an Adjunct Assistant Professor at the Icahn School of Medicine at Mount Sinai, said in a statement. Dr Marizzi also is the principal investigator of the New York City Virus Hunters (NYCVH) Program, and the director of community science at BioBus, which is an initiative to bring cutting-edge laboratory science to communities of students that have been historically underrepresented in science with the help of a converted school bus. Many migratory bird species stop over in New York City during their long journeys, which creates the ideal opportunity for different virus strains to meet and mix.

 

“Birds are key to finding out which influenza and other avian viruses are circulating in the New York City area, as well as important for understanding which ones can be dangerous to both other birds and humans,” Dr Marizzi explained. “And we need more eyes on the ground — that’s why community involvement is really critical.”  The findings were the result of a citizen scientist program to monitor the health of urban wild birds. Samples were collected by high school students in New York City who participate in both research and communication efforts as paid interns under Dr Marizzi’s expert mentorship. As part of their work, they’re provided with all the necessary protective gear to go out into the field and collect bird fecal samples, which they then help screen for viruses. Additional samples are also donated from local animal welfare centers, particularly the Wild Bird Fund, which is a local wild bird rescue. (Disclosure: I’ve been a $upporter of the Wild Bird Fund for many years.). To do this study, the junior scientist interns, or “Virus Hunters”, collected more than 2500 swabs and fecal samples in total from the Wild Bird Fund and from NYC’s parks and other natural areas across the boroughs of Manhattan, Brooklyn and the Bronx. The samples were then screened in a lab at the Icahn School of Medicine at Mount Sinai for the presence of two avian viruses: avian influenza and avian paramyxovirus. The Virus Hunters identified eight birds that were positive for avian paramyxovirus using Polymerase Chain Reaction (PCR). Two type 1 avian paramyxoviruses (APMV1, also known as Newcastle’s Disease Virus), were isolated from feral rock pigeons, Columba livia. These two viral isolates were named, reported to the USDA, and the whole genome sequences were published at the online data repository GenBank. APMV1 is a viral pathogen that affects pigeons and is present in most countries. It is a serious disease that can spread rapidly and cause high rates of pigeon illness and death. Other paramyxovirus strains may affect other avian species, particularly poultry.

 

Between January 2022 and November 2023, the Virus Hunters continued their work by collecting 1927 samples from raptors, poultry and waterfowl (Figure 1). They screened these samples specifically for H5N1, also known as bird flu. They detected the virus in six city birds representing four different species: Canada geese, Branta canadensis; red-tailed hawks, Buteo jamaicensis; peregrine falcons, Falco peregrinus; and domestic chickens, Gallus gallus domesticus. The positive samples came from the urban wildlife rehabilitation centers, highlighting the critical role that such centers can play in viral surveillance. After comparing the genomic sequences of the samples to each other and to other H5N1 viral genomes available in GenBank, the Virus Hunters found they were a mix of the Eurasian H5N1 2.3.4.4.b clade and local North American avian influenza virus genotypes. Is New York City sitting on a ticking H5N1 pandemic time bomb? “It is important to mention that, because we found H5N1 in city birds, this does not signal the start of a human influenza pandemic,” Dr Marizzi cautioned. “We know that H5N1 has been around in New York City for about 2 years and there have been no human cases reported.”

 

Currently, only one person has so far been infected by the H5N1 virus in the United States — a dairy worker in Texas. And yet despite the rarity of human H5N1 infections, this virus worries scientists that as bird flu spreads worldwide, the risk of it “jumping” the species barrier into humans continues to grow. For this reason, it’s important that people know what they can do to protect themselves from an infection with H5N1. “It’s smart to stay alert and stay away from wildlife,” Dr Marizzi advised. “This also includes preventing your pets from getting in close contact with wildlife.” Domestic cats are particularly susceptible. For example, out of 24 cats known to have contracted H5N1 on a single Texas dairy farm last month, twelve of them have died so far. If one must handle sick or injured birds or other wildlife, it is important to always use safe practices. These practices include placing a towel, blanket, jumper or pillowcase gently over the stricken animal. This will help keep it calm and aid with safe handling. If dealing with a sick or wounded bird, it is best to gently wrap it in a towel or hold the wings close to its body and place it into a paper bag or box for transport to bird rescue center.

 

Research Published in  Journal of Virology (May 15, 2024):

 
 
No comment yet.
Scooped by Juan Lama
Scoop.it!

SARS-CoV-2 Infection Induces Robust Neutralizing Antibody Responses that are Stable for at Least Three Months

SARS-CoV-2 Infection Induces Robust Neutralizing Antibody Responses that are Stable for at Least Three Months | Virus World | Scoop.it

SARS-CoV-2 has caused a global pandemic with millions infected and numerous fatalities. Questions regarding the robustness, functionality and longevity of the antibody response to the virus remain unanswered. Here we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust IgG antibody responses against the viral spike protein, based on a dataset of 19,860 individuals screened at Mount Sinai Health System in New York City.

 

We also show that titers are stable for at least a period approximating three months, and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2. Our data suggests that more than 90% of seroconverters make detectible neutralizing antibody responses and that these titers are stable for at least the near-term future...

 

Preprint available at medRxiv (July 17, 2020):

 https://doi.org/10.1101/2020.07.14.20151126

No comment yet.
Scooped by Juan Lama
Scoop.it!

Reduced Neutralizing Activity of post-SARS-CoV-2 Vaccination Serum Against Variants B.1.617.2, B.1.351, B.1.1.7+E484K and a Sub-Variant of C.37 | medRxiv

Reduced Neutralizing Activity of post-SARS-CoV-2 Vaccination Serum Against Variants B.1.617.2, B.1.351, B.1.1.7+E484K and a Sub-Variant of C.37 | medRxiv | Virus World | Scoop.it

Highly efficacious vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed. However, the emergence of viral variants that are more infectious than the earlier SARS-CoV-2 strains is concerning. Several of these viral variants have the potential to partially escape neutralizing antibody responses warranting continued immune-monitoring. Here, we tested a number of currently circulating viral variants of concern/interest, including B.1.526 (Iota), B.1.1.7+E484K (Alpha), B.1.351 (Beta), B.1.617.2 (Delta) and C.37 (Lambda) in neutralization assays using a panel of post-mRNA vaccination sera. The assays were performed with authentic SARS-CoV-2 clinical isolates in an assay that mimics physiological conditions.

 

We found only small decreases in neutralization against B.1.526 and an intermediate phenotype for B.617.2. The reduction was stronger against a sub-variant of C.37, followed by B.1.351 and B.1.1.7+E484K. C.37 is currently circulating in parts of Latin America and was detected in Germany, the US and Israel. Of note, reduction in a binding assay that also included P.1, B.1.617.1 (Kappa) and A.23.1 was negligible. Taken together, these findings suggest that mRNA SARS-CoV-2 vaccines may remain effective against these viral variants of concern/interest and that spike binding antibody tests likely retain specificity in the face of evolving SARS-CoV-2 diversity.

 

Preprint Available in medRxiV (July 23, 2021):

https://doi.org/10.1101/2021.07.21.21260961 

No comment yet.
Scooped by Juan Lama
Scoop.it!

New Blood Tests for Antibodies Could Show True Scale of Coronavirus Pandemic

New Blood Tests for Antibodies Could Show True Scale of Coronavirus Pandemic | Virus World | Scoop.it

How many COVID-19 cases have gone undetected? And are those who had mild cases of the disease—perhaps so mild they dismissed it as a cold or allergies—immune to new infections? If so, they could slow the spread of the burgeoning pandemic. Answering those questions is crucial to managing the pandemic and forecasting its course. But the answers won’t come from the RNA-based diagnostic tests now being given by the tens of thousands. They look for the presence of viral genes in a nose or throat swab, a sign of an active infection. But scientists also need to test a person’s blood for antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Such tests can detect active infections, too, but more importantly, they can tell whether a person has been infected in the past because the body retains antibodies against pathogens it has already overcome.

 

Labs and companies around the world have raced to develop antibody tests, and a few have been used in small studies and received commercial approval, including several from China. But so far, large-scale data from such tests—for example showing what fraction of people in the hard-hit city of Wuhan, China, might now be immune—is still lacking or at least not public. Scientists hope that will soon change as more tests become available. A new recipe could offer labs an alternative to waiting for or buying commercial tests. Florian Krammer, a virologist at the Icahn School of Medicine at Mount Sinai, and his colleagues posted a preprint yesterday describing a SARS-CoV-2 antibody test they have developed, and directions for replicating it. It’s one of the first such detailed protocols to be widely distributed, and the procedure is simple enough, he says, that other labs could easily scale it up “to screen a few thousand people a day,” and quickly amass more data on the accuracy and specificity of the test. Together with increased availability of commercial tests, that means some important answers about immunity to COVID-19, the disease caused by the novel coronavirus, may be available soon, he says.

 

To create the test, the researchers began by designing a slightly altered version of the “spike” protein on SARS-CoV-2’s outer coat. (The alterations made the protein more stable for use in the lab.) That protein helps the virus enter cells, and it is a key target in the immune reaction against the virus, as the body churns out antibodies that recognize the protein and tag the virus for destruction. They also isolated the short piece of the spike protein called the receptor-binding domain (RBD), which the virus uses to attach to cells it tries to invade. They then used cell lines to produce large quantities of the altered spike proteins and RBDs....

 

Preprint Published in medRxiv (March 18, 2020):

https://doi.org/10.1101/2020.03.17.20037713

No comment yet.